Atosiban is an oxytocin receptor antagonist used as a tocolytic to delay preterm labor. It inhibits the action of oxytocin on the uterus, reducing uterine contractions. It is administered intravenously and has fewer cardiovascular side effects compared to beta-agonist tocolytics. It is approved for use in several countries in Europe and Asia.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Atosiban and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Atosiban impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Atosiban-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
)8)-Atosiban TFA salt.jpg)
8)-Atosiban.jpg)
